Latin America High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology, Glaucoma, Hormonal Balance And Others) And By Region (Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021))

Latin America High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology, Glaucoma, Hormonal Balance And Others) And By Region (Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021))

ID: 3030 | Pages: 140 | August 2017 | Region: Latin America


The Latin America High Potency Active Pharmaceutical Ingredients Market was worth USD 2 billion in 2016 and estimated to be growing at a CAGR of 8.3%, to reach USD 3 billion by 2021. High Potency Active Pharmaceutical Ingredients (HPAPI) are pharmacological active substances and intermediates at concentrations below 150 micrograms per kilogram of body weight. They are highly selective, hence they can bind to specific receptors or enzymes which can cause cancer, reproductive problems  and developmental disorders, at low doses. Many new pharmaceutical drugs have these drugs, leading to high growth of this market.

High Potency Active Pharmaceutical Ingredients gave rise to new set of medicines to treat medical ailments, especially cancer. The mapping of human genome gave possibility for producing new cancer treating drugs not only for different cancers but also for different patients. Since they are active even at low concentrations, they have to be prepared with great care. They can cause serious health issues to workers if proper care is not taken. Safety steps are to be taken in order to prevent contamination of drugs with contaminants. So it requires specialized equipment for handling HPAPI’s and managing air quality.

Some of the driving factors of Latin America High Potency Active Pharmaceutical Ingredients market are low price, growing healthcare prices, rising government initiatives to increase the usage of generic medicines so that healthcare costs can be cut down, rising number of pharmaceutical manufacturers and patients. The restraining agents of this market are lack of skilled workers, stringent regulatory requirements and high price of equipment.

The Latin America High Potency Active Pharmaceutical Ingredients market is segmented on the basis of type into innovative HPAPI’s and generic HPAPI’s. Innovative HPAPI’s has the largest market share due to factors like many number of them being patented, higher price as compared to generics, pharmaceutical manufacturers focusing on production of new drugs and demand for novel anti-cancer medicines. Based on synthesis, the market is divided into biotech HPAPI’s and synthetic HPAPI’s. Synthetic HPAPI’s have a larger market share due to rise of new drugs in the market, ease of production, technological improvements in synthesis and approval for the production of new drugs. Based on therapeutic application, the market is segmented into oncology, glaucoma, hormonal balance and others. Oncology has the largest share in the market. Factors such as rising incidence of cancer and launch of new target therapies is the reason for rise in the therapeutic segment.

The Latin America High Potency Active Pharmaceutical Ingredients market is geographically segmented into Brazil, Argentina, Chile and others. This market is still in its initial stages in this region. Factors such as growing incidence of cancer, increased funding into cancer research and approval for the production of new drugs is expected to amplify the growth of this market in the region.

Some of the major players in the market include Pfizer, Inc. (U.S.), Novartis International AG (Switzerland), Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland), Eli Lilly and Company (U.S.), Bristol-Myers Squibb (U.S.), Boehringer Ingelheim (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Merck & Co., Inc. (U.S.), AbbVie Inc. (U.S.), and Mylan Inc. (U.S.).

 

1.Introduction                                                               

               1.1 Market Definition                                                  

               1.2 Study Deliverables                                                 

               1.3 Base Currency, Base Year and Forecast Periods                                                         

               1.4 General Study Assumptions                                                

2. Research Methodology                                                                        

               2.1 Introduction                                             

               2.2 Research Phases                                                    

                              2.2.1 Secondary Research                                          

                              2.2.2 Primary Research                                

                              2.2.3 Econometric Modelling                                    

                              2.2.4 Expert Validation                                 

               2.3 Analysis Design                                                       

               2.4 Study Timeline                                                        

3. Overview                                                                   

               3.1 Executive Summary                                               

               3.2 Key Inferences                                                        

               3.3 Epidemology                                                           

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                      

               4.1 Market Drivers                                                       

               4.2 Market Restraints                                                  

               4.3 Key Challenges                                                       

               4.4 Current Opportunities in the Market                                               

5. Market Segmentation                                                            

               5.1 Type                                                           

                              5.1.1 Innovative HPAPI's                              

                              5.1.2 Generic HPAPI's                                   

                              5.1.3  Y-o-Y Growth Analysis, By Type                                    

                              5.1.4  Market Attractiveness Analysis, By Type                                    

                              5.1.5  Market Share Analysis, By Type                                    

               5.2 Synthesis                                                   

                              5.2.1 Biotech HPAPI's                                   

                                             5.2.1.1 Biotech High- otency Active Pharmaceutical Ingredients Market, By Type               

                                                            5.2.1.1.1 Innovative Biotech HPAPIs         

                                                            5.2.1.1.2 Biosimilars       

                              5.2.2 Synthetic HPAPI's                                

                                             5.2.2.1 Synthetic High Potency Active Pharmaceutical Ingredients Market, By Type              

                                                            5.2.2.1.1 Innovative Synthetic HPAPIs      

                                                            5.2.2.1.2 Generic Synthetic HPAPIs           

                              5.2.3 Y-o-Y Growth Analysis, By Synthesis                                            

                              5.2.4 Market Attractiveness Analysis, By Synthesis                                            

                              5.2.5 Market Share Analysis, By Synthesis                                            

               5.3 Therapeutic Application                                                      

                              5.3.1 Oncology                               

                              5.3.2 Glaucoma                              

                              5.3.3 Hormonal Balance                              

                              5.3.4 Other therapeutic applications                                      

                              5.3.5 Y-o-Y Growth Analysis, By Therapeutic Application                                 

                              5.3.6  Market Attractiveness Analysis, By Therapeutic Application                               

                              5.3.7  Market Share Analysis, By Therapeutic Application                                

               5.4 Manufacturer                                                         

                              5.4.1 Captive Manufacturers                                     

                              5.4.2 Merchant Manufacturers                                 

                                             5.4.2.1 Merchant HPAPI Manufacturers Market, By Type                 

                                                            5.4.2.1.1 Innovative Merchant HPAPI Manufacturers         

                                                            5.4.2.1.2 Generic Merchant HPAPI Manufacturers              

                                             5.4.2.2 Merchant HPAPI Manufacturers Market, By Type of Synthesis                             

                                                            5.4.2.2.1 Synthetic HPAPIs           

                                                            5.4.2.2.2 Biotech HPAPIs              

                              5.4.3 Y-o-Y Growth Analysis, By Manufacturer                                    

                              5.4.4  Market Attractiveness Analysis, By Manufacturer                                  

                              5.4.5  Market Share Analysis, By Manufacturer                                   

6. Geographical Analysis                                                            

               6.1 Introduction                                             

                              6.1.1 Regional Trends                                   

                              6.1.2 Impact Analysis                                    

                              6.1.3 Y-o-Y Growth Analysis                                       

                                             6.1.3.1 By Type                

                                             6.1.3.2 By Synthesis                       

                                             6.1.3.3 By Therapeutic Application                           

                                             6.1.3.4 By Manufacturer               

                              6.1.4  Market Attractiveness Analysis                                     

                                             6.1.4.1 By Type                

                                             6.1.4.2 By Synthesis                       

                                             6.1.4.3 By Therapeutic Application                           

                                             6.1.4.4  By Manufacturer                             

                              6.1.5  Market Share Analysis                                      

                                             6.1.5.1 By Type                

                                             6.1.5.2 By Synthesis                       

                                             6.1.5.3 By Therapeutic Application                           

                                             6.1.5.4 By Manufacturer               

               6.2 Brazil                                                         

               6.3 Mexico                                                      

               6.4 Rest of Latin America                                                          

7.Strategic Analysis                                                                     

               7.1 PESTLE analysis                                                      

                              7.1.1 Political                                  

                              7.1.2 Economic                               

                              7.1.3 Social                                      

                              7.1.4 Technological                                      

                              7.1.5 Legal                                       

                              7.1.6 Environmental                                     

               7.2 Porter’s Five analysis                                            

                              7.2.1 Bargaining Power of Suppliers                                       

                              7.2.2 Bargaining Power of Consumers                                   

                              7.2.3 Threat of New Entrants                                    

                              7.2.4 Threat of Substitute Products and Services                                

                              7.2.5 Competitive Rivalry within the Industry                                      

8.Market Leaders' Analysis                                                                       

               8.1 Pfizer Inc.                                                 

                              8.1.1 Overview                                

                              8.1.2 Product Analysis                                  

                              8.1.3 Financial analysis                                 

                              8.1.4 Recent Developments                                       

                              8.1.5 SWOT analysis                                     

                              8.1.6 Analyst View                                         

               8.2 Novartis International AG                                                   

               8.3 Sanofi                                                        

               8.4 F. Hoffmann-La Roche Ltd.                                                

               8.5 Eli Lilly and Company                                                           

               8.6 Bristol-Myers Squibb                                                            

               8.7 Boehringer Ingelheim                                                          

               8.8 Teva Pharmaceutical Industries Ltd.                                                

               8.9 Merck & Co., Inc.                                                   

               8.10 AbbVie Inc.                                                            

               8.11 Mylan Inc.                                              

9.Competitive Landscape                                                                         

               9.1 Market share analysis                                                          

               9.2 Merger and Acquisition Analysis                                                       

               9.3 Agreements, collaborations and Joint Ventures                                                         

               9.4 New Product Launches                                                        

10.Market Outlook and Investment Opportunities                                                                          

Appendix                                                                        

               a) List of Tables                                              

               b) List of Figures                                            

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Latin America High Potency Active Pharmaceutical Ingredients Market By Type, From 2016-2021 ( USD Million )
  2. Latin America Innovative HPAPI's  Market By Region, From 2016-2021 ( USD Million )
  3. Latin America Generic HPAPI's Market By Region, From 2016-2021 ( USD Million )
  4. Latin America High Potency Active Pharmaceutical Ingredients Market By Synthesis, From 2016-2021 ( USD Million )
  5. Latin America Biotech HPAPI's Market By Region, From 2016-2021 ( USD Million )
  6. Latin America Synthetic HPAPI's Market By Region, From 2016-2021 ( USD Million )
  7. Latin America High Potency Active Pharmaceutical Ingredients Market By Therapeutic Application, From 2016-2021 ( USD Million )
  8. Latin America Oncology Market By Region, From 2016-2021 ( USD Million )
  9. Latin America Glaucoma Market By Region, From 2016-2021 ( USD Million )
  10. Latin America Hormonal Balance Market By Region, From 2016-2021 ( USD Million )
  11. Latin America other therapeutic applications Market By Region, From 2016-2021 ( USD Million )
  12. Brazil High Potency Active Pharmaceutical Ingredients Market By Type, From 2016-2021 ( USD Million )
  13. Brazil High Potency Active Pharmaceutical Ingredients Market By Synthesis, From 2016-2021 ( USD Million )
  14. Brazil High Potency Active Pharmaceutical Ingredients Market By Therapeutic Application, From 2016-2021 ( USD Million )
  15. Argentina High Potency Active Pharmaceutical Ingredients Market By Type, From 2016-2021 ( USD Million )
  16. Argentina High Potency Active Pharmaceutical Ingredients Market By Synthesis, From 2016-2021 ( USD Million )
  17. Argentina High Potency Active Pharmaceutical Ingredients Market By Therapeutic Application, From 2016-2021 ( USD Million )
  18. Mexico High Potency Active Pharmaceutical Ingredients Market By Type, From 2016-2021 ( USD Million )
  19. Mexico High Potency Active Pharmaceutical Ingredients Market By Synthesis, From 2016-2021 ( USD Million )
  20. Mexico High Potency Active Pharmaceutical Ingredients Market By Therapeutic Application, From 2016-2021 ( USD Million )
  21. Rest of Latin America High Potency Active Pharmaceutical Ingredients Market By Type, From 2016-2021 ( USD Million )
  22. Rest of Latin America High Potency Active Pharmaceutical Ingredients Market By Synthesis, From 2016-2021 ( USD Million )
  23. Rest of Latin America High Potency Active Pharmaceutical Ingredients Market By Therapeutic Application, From 2016-2021 ( USD Million )
Middle East And Africa Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics),...
Latin America Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User...
Asia Pacific Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User ...
Europe Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User (Hospi...
North America Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User...
Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User (Hospital, Cl...
Middle East And Africa Surface Plasmon Resonance Market By Product (Imaging System, Sensor System And Reagent) By Application (Drug Discovery, Material Sciences, Biosensor) – Industry Analysis, Size, Share, Growth...
Latin America Surface Plasmon Resonance Market By Product (Imaging System, Sensor System And Reagent) By Application (Drug Discovery, Material Sciences, Biosensor) –Latin America Industry Analysis, Size, Share, Gr...
Asia Pacific Surface Plasmon Resonance Market By Product (Imaging System, Sensor System And Reagent) By Application (Drug Discovery, Material Sciences, Biosensor) – Industry Analysis, Size, Share, Growth, Trends, ...
Europe Surface Plasmon Resonance Market By Product (Imaging System, Sensor System And Reagent) By Application (Drug Discovery, Material Sciences, Biosensor) – Industry Analysis, Size, Share, Growth, Trends, And Fo...
North America Surface Plasmon Resonance Market By Product (Imaging System, Sensor System And Reagent) By Application (Drug Discovery, Material Sciences, Biosensor) – Industry Analysis, Size, Share, Growth, Trends,...
Surface Plasmon Resonance Market By Product (Sensor System And Reagent , Imaging System) By Application (Material Sciences, Drug Discovery, Biosensor), And By Region - Global Industry Analysis, Size, Share, Growth, ...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.